These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39141982)

  • 1. Betahistine mesylate reduces the damage of blue light exposure in Drosophila model.
    Li X; Zhao Z; He J; Shen J
    J Photochem Photobiol B; 2024 Oct; 259():113009. PubMed ID: 39141982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rutin intake mitigates the injury of blue light irradiation by altering aging rates of mortality in Drosophila model.
    Tang H; Li X; Liu X; Xu Y; Shen J
    Photochem Photobiol; 2024; 100(3):524-529. PubMed ID: 37665025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily blue-light exposure shortens lifespan and causes brain neurodegeneration in
    Nash TR; Chow ES; Law AD; Fu SD; Fuszara E; Bilska A; Bebas P; Kretzschmar D; Giebultowicz JM
    NPJ Aging Mech Dis; 2019; 5():8. PubMed ID: 31636947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin alleviated damage caused by blue light to Drosophila.
    Zhong L; Tang H; Xu Y; Liu X; Shan J; Shen J
    Photochem Photobiol Sci; 2022 Dec; 21(12):2085-2094. PubMed ID: 35930192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
    Deng C; Lian J; Pai N; Huang XF
    J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification.
    Lacour M
    J Vestib Res; 2013; 23(3):139-51. PubMed ID: 24177346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent effects of blue light exposure on lifespan, neurodegeneration, and mitochondria physiology in Drosophila melanogaster.
    Song Y; Yang J; Law AD; Hendrix DA; Kretzschmar D; Robinson M; Giebultowicz JM
    NPJ Aging; 2022 Jul; 8(1):11. PubMed ID: 35927421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in lifespan and sleep:wake duration under selective monochromes of visible light in Drosophila melanogaster.
    Krittika S; Yadav P
    Biol Open; 2022 Jul; 11(7):. PubMed ID: 35735020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.
    Lacour M; Sterkers O
    CNS Drugs; 2001; 15(11):853-70. PubMed ID: 11700150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat.
    Tighilet B; Leonard J; Lacour M
    J Vestib Res; 1995; 5(1):53-66. PubMed ID: 7711948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
    Lian J; Huang XF; Pai N; Deng C
    Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of betahistine, a histamine H1 agonist and H3 antagonist, in a light/dark test in mice.
    Imaizumi M; Miyazaki S; Onodera K
    Methods Find Exp Clin Pharmacol; 1996; 18(1):19-24. PubMed ID: 8721252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senolytic Drug Quercetin Rescues Survival from Blue Light Toxicity in Drosophila Model.
    Zhang D; Shan J; Liang B; Zhong L; Tang H; Xu Y; Jin H; Chen Y; Shen J
    Photochem Photobiol; 2023; 99(4):1115-1121. PubMed ID: 36259177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blue light induces a neuroprotective gene expression program in Drosophila photoreceptors.
    Hall H; Ma J; Shekhar S; Leon-Salas WD; Weake VM
    BMC Neurosci; 2018 Jul; 19(1):43. PubMed ID: 30029619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness.
    Wang JJ; Dutia MB
    Exp Brain Res; 1995; 105(1):18-24. PubMed ID: 7589314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial.
    Wu P; Cao W; Hu Y; Li H
    BMJ Open; 2019 Jun; 9(6):e026711. PubMed ID: 31217316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of the efficacy and safety of a new modified-release betahistine formulation in the treatment of vestibular vertigo and Meniere's disease].
    Parfenov VA; Zamergrad MV; Kazei DV; Nauta J
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):42-48. PubMed ID: 33459540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.
    Scholtz AW; Steindl R; Burchardi N; Bognar-Steinberg I; Baumann W
    Clin Drug Investig; 2012 Jun; 32(6):387-99. PubMed ID: 22506537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo.
    Wan TJ; Yu YC; Zhao XG; Tang P; Gong YS
    Neuropsychiatr Dis Treat; 2018; 14():2965-2971. PubMed ID: 30464481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
    Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
    BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.